These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28980610)

  • 1. [Complex diagnostic of cognitive impairment].
    Emelin AY; Lobzin VY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6. Vyp. 2):33-40. PubMed ID: 28980610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of vascular cognitive impairment and its main categories.
    Rodríguez García PL; Rodríguez García D
    Neurologia; 2015 May; 30(4):223-39. PubMed ID: 22739039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological assessment and cerebral vascular disease: the new standards.
    Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
    Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular cognitive impairment and dementia.
    Gorelick PB; Counts SE; Nyenhuis D
    Biochim Biophys Acta; 2016 May; 1862(5):860-8. PubMed ID: 26704177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.
    Forlenza OV; Diniz BS; Teixeira AL; Stella F; Gattaz W
    Braz J Psychiatry; 2013; 35(3):284-94. PubMed ID: 24142092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group.
    Perneczky R; Tene O; Attems J; Giannakopoulos P; Ikram MA; Federico A; Sarazin M; Middleton LT
    BMC Med; 2016 Nov; 14(1):162. PubMed ID: 27806707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective cognitive decline: preclinical manifestation of Alzheimer's disease.
    Lin Y; Shan PY; Jiang WJ; Sheng C; Ma L
    Neurol Sci; 2019 Jan; 40(1):41-49. PubMed ID: 30397816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia.
    Ewers M; Sperling RA; Klunk WE; Weiner MW; Hampel H
    Trends Neurosci; 2011 Aug; 34(8):430-42. PubMed ID: 21696834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binswanger's disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia.
    Rosenberg GA
    J Neurochem; 2018 Mar; 144(5):634-643. PubMed ID: 28902409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychological disorders in patients with glaucoma].
    Bogolepova AN; Makhnovich EV; Jyravleva AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):72-76. PubMed ID: 35175705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropsychological features of mixed Alzheimer's and vascular dementia].
    Roshchina IF; Mikhaĭlova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10):11-7. PubMed ID: 24300799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive profiles in Alzheimer's disease.
    Johnson NA
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):4-5. PubMed ID: 14707295
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.
    Lange C; Suppa P; Pietrzyk U; Makowski MR; Spies L; Peters O; Buchert R;
    J Alzheimers Dis; 2018; 61(1):373-388. PubMed ID: 29154285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging biomarkers and screening for cognitive frailty.
    Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Lozupone M; Seripa D; Panza F; Yu Z
    Aging Clin Exp Res; 2017 Dec; 29(6):1075-1086. PubMed ID: 28260159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.